Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Celine Mascaux

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Thoracic Surgery Clinics|August 13, 2013
Adjuvant chemotherapy after pulmonary resection for lung cancerCeline Mascaux, Frances A Shepherd
Annals of Translational Medicine|July 19, 2016
Elderly selection on geriatric index assessmentPascale Tomasini, Celine Mascaux, Fabrice Barlesi
Therapeutic Advances in Medical Oncology|May 31, 2016
Pemetrexed for advanced stage nonsquamous non-small cell lung cancer: latest evidence about its extended use and outcomesPascale Tomasini, Fabrice Barlesi, Celine Mascaux, et al.
Expert Review of Molecular Diagnostics|September 17, 2010
Early detection and screening of lung cancerCeline Mascaux, Nir Peled, Kavita Garg, et al.
Lung Cancer (Amsterdam, Netherlands)|April 9, 2022
Genomic testing among patients with newly diagnosed advanced non-small cell lung cancer in the United States: A contemporary clinical practice patterns studyLuis Paz-Ares, Adam Gondos, Diego Saldana, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|March 16, 2018
Drug repurposing in malignant pleural mesothelioma: a breath of fresh air?Arnaud Boyer, Eddy Pasquier, Pascale Tomasini, et al.
BMC Medicine|July 23, 2013
Bridging the clinical gaps: genetic, epigenetic and transcriptomic biomarkers for the early detection of lung cancer in the post-National Lung Screening Trial eraJohn F Brothers, Kahkeshan Hijazi, Celine Mascaux, et al.
International Journal of Molecular Sciences|December 22, 2016
EGFR and KRAS Mutations Predict the Incidence and Outcome of Brain Metastases in Non-Small Cell Lung CancerPascale Tomasini, Cindy Serdjebi, Nataliya Khobta, et al.
Cellular Oncology (Dordrecht, Netherlands)|April 27, 2013
Insulin-like growth factor-1 receptor (IGF-1R) as a biomarker for resistance to the tyrosine kinase inhibitor gefitinib in non-small cell lung cancerNir Peled, Murry W Wynes, Norihiko Ikeda, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 11, 2010
Novel epidermal growth factor receptor mutation-specific antibodies for non-small cell lung cancer: immunohistochemistry as a possible screening method for epidermal growth factor receptor mutationsYasufumi Kato, Nir Peled, Murry W Wynes, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Thoracic Surgery Clinics|August 13, 2013
Adjuvant chemotherapy after pulmonary resection for lung cancerCeline Mascaux, Frances A Shepherd
Annals of Translational Medicine|July 19, 2016
Elderly selection on geriatric index assessmentPascale Tomasini, Celine Mascaux, Fabrice Barlesi
Therapeutic Advances in Medical Oncology|May 31, 2016
Pemetrexed for advanced stage nonsquamous non-small cell lung cancer: latest evidence about its extended use and outcomesPascale Tomasini, Fabrice Barlesi, Celine Mascaux, et al.
Expert Review of Molecular Diagnostics|September 17, 2010
Early detection and screening of lung cancerCeline Mascaux, Nir Peled, Kavita Garg, et al.
Lung Cancer (Amsterdam, Netherlands)|April 9, 2022
Genomic testing among patients with newly diagnosed advanced non-small cell lung cancer in the United States: A contemporary clinical practice patterns studyLuis Paz-Ares, Adam Gondos, Diego Saldana, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|March 16, 2018
Drug repurposing in malignant pleural mesothelioma: a breath of fresh air?Arnaud Boyer, Eddy Pasquier, Pascale Tomasini, et al.
BMC Medicine|July 23, 2013
Bridging the clinical gaps: genetic, epigenetic and transcriptomic biomarkers for the early detection of lung cancer in the post-National Lung Screening Trial eraJohn F Brothers, Kahkeshan Hijazi, Celine Mascaux, et al.
International Journal of Molecular Sciences|December 22, 2016
EGFR and KRAS Mutations Predict the Incidence and Outcome of Brain Metastases in Non-Small Cell Lung CancerPascale Tomasini, Cindy Serdjebi, Nataliya Khobta, et al.
Cellular Oncology (Dordrecht, Netherlands)|April 27, 2013
Insulin-like growth factor-1 receptor (IGF-1R) as a biomarker for resistance to the tyrosine kinase inhibitor gefitinib in non-small cell lung cancerNir Peled, Murry W Wynes, Norihiko Ikeda, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 11, 2010
Novel epidermal growth factor receptor mutation-specific antibodies for non-small cell lung cancer: immunohistochemistry as a possible screening method for epidermal growth factor receptor mutationsYasufumi Kato, Nir Peled, Murry W Wynes, et al.
Pageof 3